COSM vs. BIMI, MEDS, MBRX, BTCY, MIRA, AKTX, ABVC, NH, ELAB, and CHRO
Should you be buying Cosmos Health stock or one of its competitors? The main competitors of Cosmos Health include BIMI (BIMI), TRxADE HEALTH (MEDS), Moleculin Biotech (MBRX), Biotricity (BTCY), MIRA Pharmaceuticals (MIRA), Akari Therapeutics (AKTX), ABVC BioPharma (ABVC), NantHealth (NH), Elevai Labs (ELAB), and Chromocell Therapeutics (CHRO). These companies are all part of the "medical" sector.
Cosmos Health (NASDAQ:COSM) and BIMI (NASDAQ:BIMI) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, media sentiment, analyst recommendations, community ranking, valuation, dividends, risk and institutional ownership.
BIMI received 5 more outperform votes than Cosmos Health when rated by MarketBeat users. However, 70.69% of users gave Cosmos Health an outperform vote while only 57.50% of users gave BIMI an outperform vote.
Cosmos Health has a beta of 5.84, suggesting that its stock price is 484% more volatile than the S&P 500. Comparatively, BIMI has a beta of 1.72, suggesting that its stock price is 72% more volatile than the S&P 500.
Cosmos Health has higher revenue and earnings than BIMI.
Cosmos Health has a net margin of -31.48% compared to BIMI's net margin of -94.58%. Cosmos Health's return on equity of -28.54% beat BIMI's return on equity.
In the previous week, Cosmos Health had 3 more articles in the media than BIMI. MarketBeat recorded 6 mentions for Cosmos Health and 3 mentions for BIMI. BIMI's average media sentiment score of 0.63 beat Cosmos Health's score of 0.54 indicating that BIMI is being referred to more favorably in the news media.
12.6% of Cosmos Health shares are held by institutional investors. Comparatively, 0.1% of BIMI shares are held by institutional investors. 18.7% of Cosmos Health shares are held by company insiders. Comparatively, 69.0% of BIMI shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Summary
Cosmos Health beats BIMI on 10 of the 14 factors compared between the two stocks.
Get Cosmos Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for COSM and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding COSM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cosmos Health Competitors List
Related Companies and Tools
